CN102488713A - Method for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrated solution - Google Patents
Method for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrated solution Download PDFInfo
- Publication number
- CN102488713A CN102488713A CN201110438853XA CN201110438853A CN102488713A CN 102488713 A CN102488713 A CN 102488713A CN 201110438853X A CN201110438853X A CN 201110438853XA CN 201110438853 A CN201110438853 A CN 201110438853A CN 102488713 A CN102488713 A CN 102488713A
- Authority
- CN
- China
- Prior art keywords
- sheep placenta
- ratio
- liquid
- placenta
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000002826 placenta Anatomy 0.000 title claims abstract description 105
- 102000008186 Collagen Human genes 0.000 title claims abstract description 32
- 108010035532 Collagen Proteins 0.000 title claims abstract description 32
- 229920001436 collagen Polymers 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 26
- 241001494479 Pecora Species 0.000 title abstract description 85
- 239000000284 extract Substances 0.000 title abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000000287 crude extract Substances 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims description 45
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 36
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 29
- 238000000108 ultra-filtration Methods 0.000 claims description 27
- 238000001223 reverse osmosis Methods 0.000 claims description 25
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 18
- 239000002893 slag Substances 0.000 claims description 17
- 238000001471 micro-filtration Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 239000013049 sediment Substances 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 9
- 108090000145 Bacillolysin Proteins 0.000 claims description 8
- 102000035092 Neutral proteases Human genes 0.000 claims description 8
- 108091005507 Neutral proteases Proteins 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 108091005658 Basic proteases Proteins 0.000 claims description 7
- 230000002421 anti-septic effect Effects 0.000 claims description 7
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 6
- 108091005508 Acid proteases Proteins 0.000 claims description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 6
- 229920002674 hyaluronan Polymers 0.000 claims description 6
- 229960003160 hyaluronic acid Drugs 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 6
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 6
- 238000003828 vacuum filtration Methods 0.000 claims description 6
- 239000000498 cooling water Substances 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 5
- 238000005119 centrifugation Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 238000000265 homogenisation Methods 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 238000010792 warming Methods 0.000 claims description 3
- -1 BAIMEISHA antiseptic Chemical compound 0.000 claims description 2
- 241000283898 Ovis Species 0.000 claims 10
- 239000012530 fluid Substances 0.000 claims 8
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 238000005267 amalgamation Methods 0.000 claims 3
- 230000003301 hydrolyzing effect Effects 0.000 claims 3
- 238000004140 cleaning Methods 0.000 claims 2
- 238000013329 compounding Methods 0.000 claims 2
- 239000008187 granular material Substances 0.000 claims 1
- 239000012141 concentrate Substances 0.000 abstract description 24
- 239000000047 product Substances 0.000 abstract description 10
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 238000006243 chemical reaction Methods 0.000 abstract description 5
- 239000003674 animal food additive Substances 0.000 abstract description 4
- 239000002699 waste material Substances 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 230000007613 environmental effect Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 239000012263 liquid product Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 26
- 229960005188 collagen Drugs 0.000 description 24
- 239000000706 filtrate Substances 0.000 description 18
- 239000012465 retentate Substances 0.000 description 17
- 238000010298 pulverizing process Methods 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 8
- 230000008929 regeneration Effects 0.000 description 8
- 238000011069 regeneration method Methods 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 239000003755 preservative agent Substances 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 230000002335 preservative effect Effects 0.000 description 6
- 108091005804 Peptidases Proteins 0.000 description 5
- 239000004365 Protease Substances 0.000 description 5
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 5
- 238000004042 decolorization Methods 0.000 description 5
- 229940088592 immunologic factor Drugs 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 239000000367 immunologic factor Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000012466 permeate Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 239000012982 microporous membrane Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000003169 placental effect Effects 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 238000010009 beating Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 210000003195 fascia Anatomy 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229960003284 iron Drugs 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 206010028417 myasthenia gravis Diseases 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
一种用羊胎盘制备羊胎盘素和羊胎盘水解胶原浓缩液的方法,属于羊胎盘的利用技术领域。本发明以市售冻干羊胎盘为原料,先制备羊胎盘粉,后制备羊胎盘素粗提取液,再制备羊胎盘素和羊胎盘水解胶原浓缩液产品。本发明具有方法简单,操作简便,设备简单,反应条件温和,节约能源;本发明方法在制备出羊胎盘素的同时,还制得羊胎盘水解胶原浓缩液及饲料添加剂等多种产品,实现了羊胎盘的综合利用;在生产过程中充分利用物质资源,无“三废”排放,有利于环保;生产成本低,便于推广应用。本发明可广泛用于制备羊胎盘素和羊胎盘水解胶原浓缩液,采用本发明制备出的产品可广泛应用于化妆品、保健品等行业中。The invention discloses a method for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrate by using sheep placenta, belonging to the technical field of sheep placenta utilization. The invention uses commercially available freeze-dried sheep placenta as a raw material, first prepares sheep placenta powder, then prepares a crude extract of sheep placenta, and then prepares sheep placenta and sheep placenta hydrolyzed collagen concentrated liquid products. The invention has the advantages of simple method, simple operation, simple equipment, mild reaction conditions, and energy saving; while the sheep placenta is prepared by the method of the invention, various products such as sheep placenta hydrolyzed collagen concentrate and feed additives are also produced, realizing the realization of Comprehensive utilization of sheep placenta; full use of material resources in the production process, no "three wastes" discharge, conducive to environmental protection; low production cost, easy to popularize and apply. The invention can be widely used for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrate, and the products prepared by adopting the invention can be widely used in industries such as cosmetics and health care products.
Description
一、技术领域 1. Technical field
本发明属于羊胎盘的利用技术领域,具体涉及利用羊胎盘制备羊胎盘素和羊胎盘水解胶原浓缩液的制备方法。The invention belongs to the technical field of utilization of sheep placenta, and in particular relates to a method for preparing sheep placenta element and sheep placenta hydrolyzed collagen concentrate by using sheep placenta.
二、背景技术 2. Background technology
羊胎盘素是指从羊胎盘中提取的多种活性物质的总称,包括多种蛋白质、必需氨基酸、核酸、荷尔蒙、胶原、免疫因子及钙铁锌等营养成分,具有补气养血、补精益肾、调节机体免疫力、延缓衰老、美白嫩肤、保持体型等多种保健功能。在临床上用于预防肝硬化、改善人体免疫力,治疗病毒性肝炎、白细胞减少症、重症肌无力等免疫性疾病以及恶性肿瘤等,也是具有神奇功效的化妆品及滋补品原料。Sheep placenta refers to the general term for a variety of active substances extracted from sheep placenta, including a variety of proteins, essential amino acids, nucleic acids, hormones, collagen, immune factors, calcium, iron and zinc and other nutrients. Kidney, regulating immunity, anti-aging, whitening and rejuvenating skin, maintaining body shape and many other health functions. It is clinically used to prevent liver cirrhosis, improve human immunity, treat viral hepatitis, leukopenia, myasthenia gravis and other immune diseases and malignant tumors. It is also a raw material for cosmetics and tonics with magical effects.
现有制备羊胎盘素的方法,如2010年3月3日公开的公开号为101658534A的“利用液氮低温排氧从羊胎盘中提取羊胎素的方法”专利,公开的方法是:在粉碎羊胎盘的同时加入液氮,粉碎环境温度24℃~25℃;将羊胎盘浆进行酶解60分钟,温度40℃,然后用生理盐水提取、无机膜过滤、超高压灭菌。该方法的主要缺点是:①未利用生产过程中产生的废渣、废液,不利于保护环境;②羊胎盘粉碎须在液氮下进行,条件苛刻,设备投入高,生产成本高;③由于未将羊胎盘中的天然肽类活性物,例如荷尔蒙、胶原、免疫因子分离就进行酶水解,而蛋白酶也水解上述活性物,因而该方法破坏了上述肽类活性物,生产的产品生物活性低;④该方法只生产出羊胎盘素一种产品,其余物质未得到充分利用,原料利用率不高。Existing methods for preparing sheep placenta, such as the patent "Method for Extracting Sheep Placenta from Sheep Placenta Using Liquid Nitrogen Low-temperature Exhaust Oxygen" with the publication number 101658534A published on March 3, 2010, the disclosed method is: Liquid nitrogen is added to the sheep placenta at the same time, and the ambient temperature is 24 ° C to 25 ° C; the sheep placenta slurry is subjected to enzymatic hydrolysis for 60 minutes at a temperature of 40 ° C, and then extracted with physiological saline, filtered with inorganic membranes, and ultra-high pressure sterilized. The main disadvantages of this method are: 1. The waste residue and waste liquid produced in the production process are not used, which is not conducive to environmental protection; The natural peptide actives in sheep placenta, such as hormones, collagen, and immune factors, are separated and then enzymatically hydrolyzed, and the protease also hydrolyzes the above-mentioned actives, so this method destroys the above-mentioned peptide actives, and the produced products have low biological activity; ④ This method only produces one product of sheep placenta, and the remaining substances are not fully utilized, and the utilization rate of raw materials is not high.
三、发明内容 3. Contents of the invention
本发明的目的是针对现有制备羊胎盘素的不足之处,提供一种用羊胎盘制备羊胎盘素和羊胎盘水解胶原浓缩液的方法。该方法具有加工工艺简单、设备常见易得、操作步骤简单实用、资源综合利用率高、环保无污染等特点。The purpose of the present invention is to provide a method for preparing sheep placenta and sheep placenta hydrolyzed collagen concentrated solution by using sheep placenta to solve the shortcomings of existing sheep placenta preparation. The method has the characteristics of simple processing technology, common and easy-to-obtain equipment, simple and practical operation steps, high comprehensive utilization rate of resources, environmental protection and no pollution, and the like.
本发明的机理是:冷冻的干燥羊胎盘中含有大量水溶性荷尔蒙、胶原、免疫因子、必需氨基酸、核酸、及钙铁锌等营养成分,能用水溶液进行提取;提取液中的大分子量胶原、免疫因子等稳定性差,容易变性析出;超滤是基于分子量差异进行分离的新技术,可分离分子量差异超过一定范围的溶质;水溶液中的大分子在高压下通过狭孔时,将被剪切、撞击等作用力碎裂成分子量较小且均匀的碎片,从而可稳定存在于水溶液中;提取胎盘素的残渣中尚存得大量组织蛋白质,可用蛋白酶专一水解成溶于水的胶原;含有胎盘营养物质的提取液以及含有胶原的水溶液经过真空浓缩,可分别制备出相应的浓缩液。Mechanism of the present invention is: the dried sheep placenta that freezes contains a large amount of nutrients such as water-soluble hormone, collagen, immune factor, essential amino acid, nucleic acid, and calcium, iron and zinc, and can be extracted with aqueous solution; Large molecular weight collagen in the extract, Immune factors have poor stability and are prone to denaturation and precipitation; ultrafiltration is a new technology for separation based on molecular weight differences, which can separate solutes with molecular weight differences exceeding a certain range; when macromolecules in aqueous solution pass through narrow holes under high pressure, they will be sheared, Impact and other forces break into smaller and uniform fragments, which can exist stably in aqueous solution; a large amount of tissue protein remains in the residue of placenta extraction, which can be specifically hydrolyzed into water-soluble collagen by protease; it contains placenta The extract solution of nutrient substance and the aqueous solution containing collagen are vacuum-concentrated to prepare corresponding concentrated solutions respectively.
本发明的目的是这样实现的:一种制备羊胎盘素和羊胎盘水解胶原浓缩液的方法:以市售冻干羊胎盘为原料,先制备羊胎盘粉,后制备羊胎盘素粗提取液,再制备羊胎盘素和羊胎盘水解胶原浓缩液。其具体方法步骤如下:The purpose of the present invention is achieved in this way: a method for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrate: using commercially available freeze-dried sheep placenta as raw material, first preparing sheep placenta powder, and then preparing sheep placenta crude extract, Then prepare sheep placenta extract and sheep placenta hydrolyzed collagen concentrate. Its specific method steps are as follows:
(1)制备羊胎盘粉(1) Prepare sheep placenta powder
以市售的冻干羊胎盘为原料,先将冻干羊胎盘置于带冷却夹套的粉碎机中,再向粉碎机的夹套中通入4~10℃的冷却水,在转速为1000~5000转/分的条件下进行粉碎5~15分钟。粉粹完成后,用40~80目的分样筛进行筛分,分别收集过筛的粉末和未过筛的颗粒。对于收集的过筛的粉末,用于下一步制备羊胎盘素粗提取液;对于未过筛的颗粒,返回粉碎机中,再进行粉碎。Using commercially available freeze-dried sheep placenta as raw material, first place the freeze-dried sheep placenta in a pulverizer with a cooling jacket, and then pour cooling water at 4 to 10°C into the jacket of the pulverizer, at a speed of 1000 The pulverization is carried out for 5-15 minutes under the condition of ~5000 rpm. After the pulverization is completed, sieve with a 40-80 mesh sieve, and collect the sifted powder and unsifted particles respectively. The collected sieved powder is used in the next step to prepare the crude sheep placenta extract; the unsifted particles are returned to the pulverizer for further pulverization.
(2)制备羊胎盘素粗提取液(2) Preparation of Sheep Placenta Crude Extract
第(1)步完成后,按照第(1)步收集的过40~80目分样筛粉末的质量(g)∶质量浓度为0.05~0.5%的NaCl溶液的体积(mL)比为1∶50~80的比例,将过筛粉末加入到NaCl溶液中,搅拌混合均匀后,再在4~8℃的温度下,进行搅拌提取4~5小时。提取完成后,将提取液泵入管式离心机中,在6000~10000转/分的转速下,进行离心分离,分别收集离心清液和离心沉淀。对于收集的离心清液,用于制备羊胎盘素;对于收集的离心沉淀,用于制备羊胎盘水解胶原浓缩液。After the (1) step was completed, the mass (g) of crossing the 40~80 mesh sieve powder collected according to the step (1): mass concentration was that the volume (mL) ratio of the NaCl solution of 0.05~0.5% was 1: Add the sieved powder into the NaCl solution at a ratio of 50 to 80, stir and mix evenly, and then carry out stirring and extraction at a temperature of 4 to 8°C for 4 to 5 hours. After the extraction is completed, the extract is pumped into a tubular centrifuge, centrifuged at a speed of 6,000 to 10,000 rpm, and the centrifuged liquid and centrifuged sediment are collected respectively. The collected centrifugal supernatant is used to prepare sheep placenta; the collected centrifugal precipitate is used to prepare sheep placenta hydrolyzed collagen concentrate.
(3)制备羊胎盘素(3) Preparation of sheep placenta
第(2)步完成后,将第(2)步收集的离心清液泵入截留分子量为2000~10000Da的超滤机中,在0.05~0.2MPa下,进行超滤分离,直至离心清液体积减少至原体积的1/3~1/6时为止,分别收集超滤滤过液和超滤截留液。对于收集的超滤滤过液,可再利用;将收集的超滤截留液,泵入高压均质机中,在20~60MPa下进行高压均质,收集泵出液,即制备出高压均质液;After step (2) is completed, pump the centrifuge liquid collected in step (2) into an ultrafiltration machine with a molecular weight cut-off of 2000-10000 Da, and perform ultrafiltration separation at 0.05-0.2 MPa until the volume of the centrifuge liquid is When it is reduced to 1/3-1/6 of the original volume, collect the ultrafiltration filtrate and ultrafiltration retentate respectively. The collected ultrafiltration filtrate can be reused; pump the collected ultrafiltration retentate into a high-pressure homogenizer, perform high-pressure homogenization at 20-60 MPa, collect the pumped liquid, and prepare a high-pressure homogenizer liquid;
再将收集的泵出液(即高压均质液)与所收集的超滤滤过液合并后,泵入脱色釜中,按照活性炭的质量(g)∶合并液的体积(mL)比为1∶10~30的比例,在合并液中加入活性炭,在室温下进行搅拌脱色10~20分钟,再泵入真空抽滤机中,进行真空抽滤,分别收集滤过液和滤渣。对于收集的滤渣,送到活性炭再生工厂进行再生,可再利用;After the collected pump out liquid (i.e. high-pressure homogeneous liquid) is combined with the collected ultrafiltration filtrate, it is pumped into the decolorization kettle, according to the quality (g) of activated carbon: the volume (mL) ratio of the combined solution is 1 : the ratio of 10 to 30, adding activated carbon to the combined solution, stirring and decolorizing at room temperature for 10 to 20 minutes, then pumping it into a vacuum filter, performing vacuum filtration, and collecting the filtrate and filter residue respectively. The collected filter residue is sent to the activated carbon regeneration plant for regeneration and can be reused;
然后将收集的滤过液,泵入反渗透器中,进行反渗透浓缩,至反渗透截留液中的可溶性固形物含量达到5~8%时为止,分别收集反渗透渗过液和反渗透截留液。对于收集的反渗透渗过液,可用于第(2)步再次提取羊胎盘素;对于收集的反渗透截留液,按照反渗透截留液∶1%透明质酸∶甘油∶百霉杀防腐剂的体积比为1∶0.05~0.08∶0.08~0.1∶0.005~0.01的比例,在反渗透截留液中加入透明质酸、甘油及百霉杀防腐剂,搅拌混合均匀后,泵入微孔滤器中,用0.22~0.45um的微孔滤膜进行微滤,用于除去微生物及不溶性杂质。微滤完成后,分别收集微滤滤过液和微滤截留物。对收集的微滤截留物,经处理达标后排放;对收集的微滤滤过液,即为制备出的羊胎盘素。Then the collected filtrate is pumped into the reverse osmosis device for reverse osmosis concentration until the soluble solids content in the reverse osmosis retentate reaches 5-8%, and the reverse osmosis permeate and reverse osmosis retained liquid. For the collected reverse osmosis permeate, it can be used for (2) step to extract sheep placenta again; The volume ratio is 1: 0.05-0.08: 0.08-0.1: 0.005-0.01. Add hyaluronic acid, glycerin and antiseptic preservative to the reverse osmosis retentate, stir and mix evenly, and then pump it into the microporous filter. Use a 0.22-0.45um microporous membrane for microfiltration to remove microorganisms and insoluble impurities. After microfiltration is completed, the microfiltration filtrate and microfiltration retentate are collected separately. The collected microfiltration retentate is discharged after being treated up to the standard; the collected microfiltration filtrate is the prepared sheep placenta.
(4)制备羊胎盘水解胶原浓缩液(4) Preparation of sheep placenta hydrolyzed collagen concentrate
第(3)步完成后,按照第(2)步收集的离心沉淀的质量(g)∶纯净水的体积(mL)比为1∶3~8的比例,在所述的离心沉淀中加入纯净水,并泵入高速匀浆机中进行打浆后,用40~80目的分样筛进行筛分,分别收集过筛液和未过筛的渣(即羊胎盘的筋膜)。对于未过筛的渣,按照未过筛的渣的质量(g)∶纯净水洗涤剂的体积(mL)之比为1∶30的比例,用纯净水对未过筛的渣进行洗涤,分别收集洗涤液和洗涤渣。对最后收集的洗涤渣,经处理达标后排放;最后将过筛液与洗涤液合并,即制备出胎盘渣匀浆液。After the (3) step is completed, according to the mass (g) of the centrifugal precipitate collected in the (2) step: the volume (mL) ratio of pure water is 1: 3~8 ratio, in the described centrifugal precipitate, add pure water, and pumped into a high-speed homogenizer for beating, and then sieved with a 40-80 mesh sieve to collect the sieved liquid and the unsifted slag (ie, the fascia of sheep placenta). For the unsifted slag, according to the ratio of the mass (g) of the unsifted slag: the volume (mL) of pure water detergent is 1:30, the unsifted slag is washed with pure water, respectively Collect the washing liquid and washing residue. The washing slag collected at the end is discharged after being treated up to the standard; finally, the sieved liquid and the washing liquid are combined to prepare a placental residue homogenate.
然后将胎盘渣匀浆液泵入反应釜中,搅拌升温至50~60℃,并用氢氧化钠溶液调节其pH值为8~9,再按照泵入反应釜中的胎盘渣匀浆液的体积(mL)∶碱性蛋白酶的质量(g)∶中性蛋白酶的质量(g)∶酸性蛋白酶的质量(g)比为1∶0.02~0.03∶0.02~0.03∶0.02~0.03的比例,向反应釜中依次分别加入碱性蛋白酶、中性蛋白酶、酸性蛋白酶,并分别在50~60℃的恒温下搅拌水解40~60分钟。连续水解完成后,将水解液泵入管式离心机中,在3000~8000转/分的转速下,进行离心分离,分别收集离心清液和离心沉淀。对于收集的离心沉淀,经烘干后粉碎,可用作饲料添加剂;对于收集的离心清液,泵入脱色釜中,按照活性炭的质量(g)∶合并液的体积(mL)比为1∶10~30的比例,加入活性炭,并升温至80~100℃,进行搅拌脱色10~20分钟后,将脱色液泵入抽滤机中,进行真空抽滤,分别收集滤过液和滤渣。对于收集的滤渣,送至活性炭再生工厂进行再生,可再利用。Then pump the placenta residue homogenate into the reaction kettle, stir and heat up to 50-60°C, and adjust its pH value to 8-9 with sodium hydroxide solution, then according to the volume of the placenta residue homogenate pumped into the reaction kettle (mL ): the mass (g) of alkaline protease: the mass (g) of neutral protease: the mass (g) ratio of acidic protease is the ratio of 1: 0.02~0.03: 0.02~0.03: 0.02~0.03, successively in the reactor Add alkaline protease, neutral protease and acid protease respectively, and stir and hydrolyze at a constant temperature of 50-60° C. for 40-60 minutes respectively. After the continuous hydrolysis is completed, the hydrolyzate is pumped into the tubular centrifuge, and centrifuged at a speed of 3000-8000 rpm, and the centrifuge supernatant and centrifuge sediment are collected respectively. For the collected centrifuge, it can be used as feed additive after being dried and pulverized; for the collected centrifuge, it is pumped into the decolorization kettle, according to the mass (g) of activated carbon: the volume (mL) ratio of the combined solution is 1: Add activated carbon at a ratio of 10 to 30, and heat up to 80 to 100°C, stir and decolorize for 10 to 20 minutes, then pump the decolorized solution into a suction filter, perform vacuum filtration, and collect the filtrate and filter residue separately. The collected filter residue is sent to the activated carbon regeneration plant for regeneration and can be reused.
最后将收集的滤过液泵入真空浓缩机中,在真空度为0.04~0.08MPa,温度为60~100℃的条件下,进行真空浓缩,直至浓缩液中可溶性固形物浓度达到20%~25%时为止,收集真空浓缩液。对于收集的真空浓缩液,泵入调配釜中,按照真空浓缩液∶甘油∶百霉杀防腐剂∶羧甲基纤维素钠的体积比为1∶0.08~0.1∶0.005~0.01∶0.01~0.03的比例,在调配釜中加入甘油、百霉杀防腐剂、羧甲基纤维素钠,搅拌混合均匀,就制备出短肽含量为15%~20%的羊胎盘水解胶原浓缩液。Finally, pump the collected filtrate into a vacuum concentrator, and carry out vacuum concentration at a vacuum degree of 0.04-0.08MPa and a temperature of 60-100°C until the concentration of soluble solids in the concentrate reaches 20%-25% %, collect the vacuum concentrate. For the collected vacuum concentrate, pump it into the preparation kettle, according to the volume ratio of vacuum concentrate: glycerin: 100 mold antiseptics: sodium carboxymethyl cellulose is 1: 0.08~0.1: 0.005~0.01: 0.01~0.03 According to the ratio, glycerin, chlorothalonide preservative and sodium carboxymethyl cellulose are added into a mixing kettle, stirred and mixed evenly, and the sheep placenta hydrolyzed collagen concentrated solution with a short peptide content of 15% to 20% is prepared.
本发明采用上述技术方案后,主要有以下效果:After the present invention adopts above-mentioned technical scheme, mainly have following effect:
1.本发明方法在生产过程中使用NaCl溶液提取、离心、酶水解、微孔过滤、超滤及真空浓缩等简单工艺,操作简便,设备简单,反应条件温和,节约能源,生产成本低,便于推广应用。1. The method of the present invention uses simple techniques such as NaCl solution extraction, centrifugation, enzymatic hydrolysis, microporous filtration, ultrafiltration and vacuum concentration in the production process, easy to operate, simple equipment, mild reaction conditions, energy saving, low production cost, and convenient Promote apps.
2.本发明方法在生产过程中实现了羊胎盘的综合利用。本发明在制备出羊胎盘素的同时,还得到了羊胎盘水解胶原浓缩液以及饲料添加剂等副产品,获得的产品多、收得率高,进一步降低了生产成本。2. The method of the present invention realizes the comprehensive utilization of sheep placenta in the production process. When the sheep placenta extract is prepared in the invention, by-products such as sheep placenta hydrolyzed collagen concentrate and feed additives are also obtained, the obtained products are many, the yield is high, and the production cost is further reduced.
3.本发明方法在工艺过程中的物料均实现循环利用,无“三废”排放,副产物得到回收利用或处理达标后排放,这不但进一步降低了生产成本,又保护环境。3. The materials in the process of the method of the present invention are all recycled, without the discharge of "three wastes", and the by-products are recycled or discharged after being treated up to the standard, which not only further reduces the production cost, but also protects the environment.
4.本发明生产工艺生产的羊胎盘素,保留了荷尔蒙、胶原、免疫因子等活性物质,可用于制备面膜,眼贴等皮肤用品,易于皮肤吸收,具有防皱、润肤、恢复皮肤靓丽的功能;生产的羊胎盘水解胶原浓缩液,可添加到保健品中,增强抵抗力和免疫力。4. The sheep placenta produced by the production process of the present invention retains active substances such as hormones, collagen, and immune factors, and can be used to prepare skin products such as facial masks and eye patches. Function; the produced sheep placenta hydrolyzed collagen concentrate can be added to health care products to enhance resistance and immunity.
本发明可广泛用于制备羊胎盘素和羊胎盘水解胶原浓缩液。采用本发明方法制备出的产品可广泛应用于化妆品、保健品等行业中。The invention can be widely used for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrate. The product prepared by the method of the invention can be widely used in industries such as cosmetics and health care products.
四、具体实施方式 4. Specific implementation
下面结合具体实施方式,进一步说明本发明。The present invention will be further described below in combination with specific embodiments.
实施例1Example 1
一种用羊胎盘制备羊胎盘素和羊胎盘水解胶原浓缩液的方法,其具体步骤如下。A method for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrate by using sheep placenta, the specific steps are as follows.
(1)制备羊胎盘粉(1) Prepare sheep placenta powder
以市售的冻干羊胎盘为原料,先将冻干羊胎盘置于带冷却夹套的粉碎机中,再向粉碎机的夹套中通入4℃的冷却水,在转速为1000转/分的条件下进行粉碎5分钟。粉粹完成后,用40目的分样筛进行筛分,分别收集过筛的粉末和未过筛的颗粒。对于收集的过筛的粉末,用于下一步制备羊胎盘素粗提取液;对于未过筛的颗粒,返回粉碎机中,再进行粉碎。Using commercially available freeze-dried sheep placenta as raw material, first place the freeze-dried sheep placenta in a pulverizer with a cooling jacket, and then pour cooling water at 4°C into the jacket of the pulverizer, at a speed of 1000 rpm The pulverization was carried out for 5 minutes under the condition of minute. After the pulverization is completed, sieve with a 40-mesh sieve, and collect the sieved powder and unsifted particles respectively. The collected sieved powder is used in the next step to prepare the crude sheep placenta extract; the unsifted particles are returned to the pulverizer for further pulverization.
(2)制备羊胎盘素粗提取液(2) Preparation of Sheep Placenta Crude Extract
第(1)步完成后,按照第(1)步收集的过40目分样筛粉末的质量(g)∶质量浓度为0.05%的NaCl溶液的体积(mL)比为1∶50的比例,将过筛粉末加入到NaCl溶液中,搅拌混合均匀后,再在4℃的温度下,进行搅拌提取4小时。提取完成后,将提取液泵入管式离心机中,在6000转/分的转速下,进行离心分离,分别收集离心清液和离心沉淀。对于收集的离心清液,用于制备羊胎盘素;对于收集的离心沉淀,用于制备羊胎盘水解胶原浓缩液。After the (1) step was completed, the mass (g) of crossing the 40 mesh sieve powder collected according to the (1) step: the volume (mL) ratio of the NaCl solution with a mass concentration of 0.05% was a ratio of 1:50, The sieved powder was added into the NaCl solution, stirred and mixed evenly, and then stirred and extracted at a temperature of 4° C. for 4 hours. After the extraction is completed, the extract is pumped into a tubular centrifuge, and centrifuged at a speed of 6000 rpm to collect the centrifuge supernatant and centrifuge sediment respectively. The collected centrifugal supernatant is used to prepare sheep placenta; the collected centrifugal precipitate is used to prepare sheep placenta hydrolyzed collagen concentrate.
(3)制备羊胎盘素(3) Preparation of sheep placenta
第(2)步完成后,将第(2)步收集的离心清液泵入截留分子量为2000Da的超滤机中,在0.05MPa下,进行超滤分离,直至离心清液体积减少至原体积的1/3时为止,分别收集超滤滤过液和超滤截留液。对于收集的超滤滤过液,可再利用;将收集的超滤截留液,泵入高压均质机中,在20MPa下进行高压均质,收集泵出液,即制备出高压均质液;After step (2) is completed, pump the centrifuge liquid collected in step (2) into an ultrafiltration machine with a molecular weight cut-off of 2000Da, and perform ultrafiltration separation at 0.05MPa until the volume of the centrifuge liquid is reduced to the original volume Up to 1/3 of the time, the ultrafiltration filtrate and the ultrafiltration retentate were collected respectively. The collected ultrafiltration filtrate can be reused; pump the collected ultrafiltration retentate into a high-pressure homogenizer, perform high-pressure homogenization at 20MPa, collect the pumped liquid, and prepare a high-pressure homogeneous liquid;
再将收集的泵出液(即高压均质液)与所收集的超滤滤过液合并后,泵入脱色釜中,按照活性炭的质量(g)∶合并液的体积(mL)比为1∶10的比例,在合并液中加入活性炭,在室温下进行搅拌脱色10分钟。然后将脱色液泵入真空抽滤机中,进行真空抽滤,分别收集滤过液和滤渣。对于收集的滤渣,送到活性炭再生工厂进行再生,可再利用;After the collected pump out liquid (i.e. high-pressure homogeneous liquid) is combined with the collected ultrafiltration filtrate, it is pumped into the decolorization kettle, according to the quality (g) of activated carbon: the volume (mL) ratio of the combined solution is 1 : ratio of 10, add activated carbon to the combined solution, and stir and decolorize at room temperature for 10 minutes. Then pump the decolorized liquid into a vacuum suction filter, carry out vacuum suction filtration, and collect the filtrate and filter residue respectively. The collected filter residue is sent to the activated carbon regeneration plant for regeneration and can be reused;
然后将收集的滤过液,泵入反渗透器中,进行反渗透浓缩,至反渗透截留液中可溶性固形物含量达到5%时为止,分别收集反渗透渗过液和反渗透截留液。对于收集的反渗透渗过液,可用于第(2)步再次提取羊胎盘素;对于收集的反渗透截留液,按照反渗透截留液∶1%透明质酸∶甘油∶百霉杀防腐剂的体积比为1∶0.05∶0.08∶0.005的比例,在反渗透截留液中加入透明质酸、甘油及百霉杀防腐剂,搅拌混合均匀后,泵入微孔滤器中,用0.22um的微孔滤膜进行微滤,用于除去微生物及不溶性杂质。微滤完成后,分别收集微滤滤过液和微滤截留物。对收集的微滤截留物,经处理达标后排放;对收集的微滤滤过液,即为制备出的羊胎盘素。Then the collected filtrate is pumped into the reverse osmosis device for reverse osmosis concentration until the soluble solid content in the reverse osmosis retentate reaches 5%, and the reverse osmosis permeate and the reverse osmosis retentate are collected respectively. For the collected reverse osmosis permeate, it can be used for (2) step to extract sheep placenta again; The volume ratio is 1: 0.05: 0.08: 0.005. Add hyaluronic acid, glycerin and antiseptic preservative to the reverse osmosis retentate, stir and mix evenly, pump into the microporous filter, and use 0.22um microporous The filter membrane is used for microfiltration to remove microorganisms and insoluble impurities. After microfiltration is completed, the microfiltration filtrate and microfiltration retentate are collected separately. The collected microfiltration retentate is discharged after being treated up to the standard; the collected microfiltration filtrate is the prepared sheep placenta.
(4)制备羊胎盘水解胶原浓缩液(4) Preparation of sheep placenta hydrolyzed collagen concentrate
第(3)步完成后,按照第(2)步收集的离心沉淀的质量(g)∶纯净水的体积(mL)比为1∶3的比例,在离心沉淀中加入纯净水,并泵入高速匀浆机中进行打浆后,用40目的分样筛进行筛分,分别收集过筛液和未过筛的渣(即羊胎盘的筋膜)。对于未过筛的渣,按照未过筛的渣的质量(g)∶纯净水洗涤剂的体积(mL)之比为1∶30的比例,用纯净水对未过筛的渣进行洗涤,分别收集洗涤液和洗涤渣。对最后收集的洗涤渣,经处理达标后排放;最后将过筛液与洗涤液合并,即制备出胎盘渣匀浆液。After the 3rd step is finished, according to the mass (g) of the centrifuge sediment collected in the step (2): the volume (mL) ratio of pure water is the ratio of 1: 3, add pure water in the centrifuge sediment, and pump into After beating in a high-speed homogenizer, sieve with a 40-mesh sampling sieve, and collect the sieved liquid and unsifted slag (ie, the fascia of sheep placenta) respectively. For the unsifted slag, according to the ratio of the mass (g) of the unsifted slag: the volume (mL) of pure water detergent is 1:30, the unsifted slag is washed with pure water, respectively Collect the washing liquid and washing residue. The washing slag collected at the end is discharged after being treated up to the standard; finally, the sieved liquid and the washing liquid are combined to prepare a placental residue homogenate.
然后将胎盘渣匀浆液泵入反应釜中,搅拌升温至50℃,并用氢氧化钠溶液调节其pH值为8,再按照泵入反应釜中的胎盘渣匀浆液的体积(mL)∶碱性蛋白酶的质量(g)∶中性蛋白酶的质量(g)∶酸性蛋白酶的质量(g)比为1∶0.02∶0.02∶0.02的比例,向反应釜中依次分别加入碱性蛋白酶、中性蛋白酶、酸性蛋白酶,并分别在50℃的恒温下搅拌水解40分钟。连续水解完成后,将水解液泵入管式离心机中,在3000转/分的转速下,进行离心分离,分别收集离心清液和离心沉淀。对于收集的离心沉淀,经烘干后粉碎,可用作饲料添加剂;对于收集的离心清液,泵入脱色釜中,按照活性炭的质量(g)∶合并液的体积(mL)比为1∶10的比例,加入活性炭,并升温至80℃,进行搅拌脱色10分钟后,将脱色液泵入抽滤机中,进行真空抽滤,分别收集滤过液和滤渣。对于收集的滤渣,送至活性炭再生工厂进行再生,可再利用。Then placenta dregs homogenate is pumped into the reactor, stirred and heated to 50°C, and its pH value is adjusted to 8 with sodium hydroxide solution, then according to the volume (mL) of the placenta dregs homogenate pumped into the reactor: alkaline The quality (g) of protease: the quality (g) of neutral protease: the mass (g) ratio of acidic protease is the ratio of 1: 0.02: 0.02: 0.02, adds alkaline protease, neutral protease, acid protease, and hydrolyzed at a constant temperature of 50°C for 40 minutes. After the continuous hydrolysis is completed, the hydrolyzate is pumped into a tubular centrifuge, and centrifuged at a speed of 3000 rpm to collect the centrifuge supernatant and centrifuge sediment respectively. For the collected centrifuge, it can be used as feed additive after being dried and pulverized; for the collected centrifuge, it is pumped into the decolorization kettle, according to the mass (g) of activated carbon: the volume (mL) ratio of the combined solution is 1: Add activated carbon at a ratio of 10, and raise the temperature to 80°C, stir and decolorize for 10 minutes, then pump the decolorized solution into a suction filter, perform vacuum filtration, and collect the filtrate and filter residue respectively. The collected filter residue is sent to the activated carbon regeneration plant for regeneration and can be reused.
最后将收集的滤过液泵入真空浓缩机中,在真空度为0.04MPa,温度为60℃的条件下,进行真空浓缩,直至浓缩液中可溶性固形物浓度达到20%时为止,分别收集真空浓缩液。对于收集的真空浓缩液,泵入调配釜中,按照真空浓缩液∶甘油∶百霉杀防腐剂∶羧甲基纤维素钠的体积比为1∶0.08∶0.005∶0.01的比例,在调配釜中加入甘油、百霉杀防腐剂、羧甲基纤维素钠,搅拌混合均匀,就制备出短肽含量为15%的羊胎盘水解胶原浓缩液。Finally, the collected filtrate is pumped into a vacuum concentrator, and vacuum concentrated at a vacuum of 0.04MPa and a temperature of 60°C until the concentration of soluble solids in the concentrated solution reaches 20%. Concentrate. For the collected vacuum concentrate, it is pumped into the blending kettle, and according to the volume ratio of vacuum concentrate: glycerol: 100 mold preservatives: sodium carboxymethyl cellulose is 1: 0.08: 0.005: 0.01, in the blending kettle Adding glycerin, chlorothalonid preservative and sodium carboxymethyl cellulose, stirring and mixing evenly, the sheep placenta hydrolyzed collagen concentrated solution with a short peptide content of 15% is prepared.
实施例2Example 2
一种用羊胎盘制备羊胎盘素和羊胎盘水解胶原浓缩液的方法,同实施例1,其中:A method for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrate with sheep placenta, same as embodiment 1, wherein:
第(1)步中,冷却水温度为8℃,粉碎时间10分钟,粉粹完成后,过60目的分样筛。In step (1), the cooling water temperature is 8° C., and the pulverization time is 10 minutes. After the pulverization is completed, pass through a 60-mesh sieve.
第(2)步中,第(1)步收集的过筛的粉末的质量(g)∶0.2%NaCl溶液体积(mL)比为1∶60,提取温度6℃,提取时间4.5小时。离心机转速为8000转/分。In the (2) step, the mass (g) of the sieved powder collected in the (1) step: the volume (mL) ratio of 0.2% NaCl solution is 1: 60, the extraction temperature is 6° C., and the extraction time is 4.5 hours. The centrifuge speed is 8000 rpm.
第(3)步中,超滤膜的截留分子量为5000Da,超滤压力为0.1MPa,超滤至离心清液体积减少至原体积的1/5时为止,高压均质压力为40MPa。In the (3) step, the molecular weight cut-off of the ultrafiltration membrane is 5000Da, and the ultrafiltration pressure is 0.1MPa. When the ultrafiltration is reduced to 1/5 of the original volume, the high-pressure homogeneous pressure is 40MPa.
活性炭的质量(g)∶合并液的体积(mL)比为1∶20,升温至90℃,搅拌脱色15分钟。The mass (g) of activated carbon: the volume (mL) ratio of the combined liquid is 1:20, the temperature is raised to 90°C, and the mixture is stirred for 15 minutes to decolorize.
反渗透截留液中可溶性固形物含量为7%,反渗透截留液∶1%透明质酸∶甘油∶百霉杀防腐剂的体积比为1∶0.06∶0.09∶0.008,微孔滤膜孔径为0.45um。The soluble solids content in the reverse osmosis retentate is 7%, the volume ratio of reverse osmosis retentate: 1% hyaluronic acid: glycerin: balmicide preservative is 1: 0.06: 0.09: 0.008, and the microporous membrane aperture is 0.45 um.
第(4)步中,离心沉淀的质量(g)∶纯净水的体积(mL)比为1∶5,用60目分样筛进行筛分。In the (4) step, the mass (g) of the centrifuged sediment: the volume (mL) ratio of pure water is 1: 5, and is sieved with a 60-mesh sieve.
搅拌升温至55℃,pH为8.5,泵入反应釜的胎盘渣匀浆液的体积(mL)∶碱性蛋白酶的质量(g)∶中性蛋白酶的质量(g)∶酸性蛋白酶的质量(g)的比为1∶0.025∶0.025∶0.025,在55℃的恒温下搅拌水解50分钟,离心机转速为5000转/分。活性炭的质量(g)∶离心清液的体积(mL)比为1∶20,升温至90℃,脱色15分钟。Stirring is warming up to 55 DEG C, pH is 8.5, the volume (mL) of the homogenate liquid of the placenta residue that pumps into reactor: the quality (g) of alkaline protease: the quality (g) of neutral protease: the quality (g) of acid protease The ratio of 1:0.025:0.025:0.025 was stirred and hydrolyzed at a constant temperature of 55° C. for 50 minutes, and the speed of the centrifuge was 5000 rpm. The mass (g) of activated carbon: the volume (mL) ratio of the centrifugal supernatant was 1:20, the temperature was raised to 90° C., and the color was decolorized for 15 minutes.
进行真空浓缩的真空度为0.06MPa,温度为80℃,至浓缩液中可溶性固形物浓度达到22%时为止;真空浓缩液∶甘油∶百霉杀防腐剂∶羧甲基纤维素钠的体积比为1∶0.09∶0.008∶0.02,制备出的羊胎盘水解胶原浓缩液中短肽含量为17%。Carrying out the vacuum tightness of vacuum concentration is 0.06MPa, and temperature is 80 ℃, till when the soluble solids concentration reaches 22% in the concentrated solution; The ratio is 1:0.09:0.008:0.02, and the short peptide content in the prepared sheep placenta hydrolyzed collagen concentrate is 17%.
实施例3Example 3
一种用羊胎盘制备羊胎盘素和羊胎盘肽的方法,同实施例1,其中:A method for preparing sheep placenta and sheep placenta peptide with sheep placenta, same as embodiment 1, wherein:
第(1)步中,冷却水温度为10℃,粉碎时间15分钟,粉粹完成后,过80目的分样筛。In the (1) step, the temperature of the cooling water is 10° C., and the pulverization time is 15 minutes. After the pulverization is completed, pass through an 80-mesh sieve.
第(2)步中,过筛的粉末的质量(g)∶0.5%NaCl溶液体积(mL)比为1∶80,提取温度8℃,提取时间5小时,离心机转速为10000转/分。In the 2nd step, the mass (g) of the powder of sieving: 0.5%NaCl solution volume (mL) ratio is 1: 80, extraction temperature 8 ℃, extraction time 5 hours, centrifuge speed is 10000 rpm.
第(3)步中,超滤膜的截留分子量为10000Da,超滤压力为0.2MPa,超滤至离心清液体积减少至原体积的1/6时为止,高压均质压力为60MPa。In the (3) step, the molecular weight cut-off of the ultrafiltration membrane is 10000Da, and the ultrafiltration pressure is 0.2MPa. When the ultrafiltration is reduced to 1/6 of the original volume, the high-pressure homogeneous pressure is 60MPa.
活性炭的质量(g)∶合并液的体积(mL)比为1∶30,升温至100℃,搅拌脱色20分钟。The mass (g) of activated carbon: the volume (mL) ratio of the combined solution is 1:30, the temperature is raised to 100°C, and the mixture is stirred for 20 minutes to decolorize.
反渗透截留液中可溶性固形物含量为8%,反渗透截留液∶1%透明质酸∶甘油∶百霉杀防腐剂的体积比为1∶0.08∶0.1∶0.01,微孔滤膜孔径为0.45um。The soluble solids content in the reverse osmosis retentate is 8%, the volume ratio of reverse osmosis retentate: 1% hyaluronic acid: glycerin: balmicide preservative is 1: 0.08: 0.1: 0.01, and the pore size of the microporous membrane is 0.45 um.
第(4)步中,离心沉淀的质量(g)∶纯净水的体积(mL)比为1∶8,用80目分样筛进行筛分。In the (4) step, the mass (g) of the centrifuged sediment: the volume (mL) ratio of pure water is 1: 8, and is sieved with 80 mesh sieves.
搅拌升温至60℃,pH为9,泵入反应釜的胎盘渣匀浆液的体积(mL)∶碱性蛋白酶的质量(g)∶中性蛋白酶的质量(g)∶酸性蛋白酶的质量(g)的比为1∶0.03∶0.03∶0.03,在60℃的恒温下搅拌水解60分钟。离心机转速为8000转/分,活性炭的质量(g)∶离心清液的体积(mL)比为1∶30,升温至100℃,脱色20分钟。Stirring is heated up to 60 DEG C, pH is 9, the volume (mL) of the placental residue homogenate pumped into reaction kettle: the quality (g) of alkaline protease: the quality (g) of neutral protease: the quality (g) of acid protease The ratio of 1:0.03:0.03:0.03 was stirred and hydrolyzed at a constant temperature of 60° C. for 60 minutes. The rotating speed of the centrifuge is 8000 rpm, the mass (g) of activated carbon: the volume (mL) ratio of the supernatant liquid is 1:30, the temperature is raised to 100° C., and the decolorization takes 20 minutes.
进行真空浓缩的真空度为0.08MPa,温度为100℃,至浓缩液中可溶性固形物浓度达到25%时为止;真空浓缩液∶甘油∶百霉杀防腐剂∶羧甲基纤维素钠的体积比为1∶0.1∶0.01∶0.03,制备出的羊胎盘水解胶原浓缩液中短肽含量为20%。Carrying out the vacuum degree of vacuum concentration is 0.08MPa, and temperature is 100 ℃, till when the concentration of soluble solids in the concentrated solution reaches 25%; The ratio is 1:0.1:0.01:0.03, and the short peptide content in the prepared sheep placenta hydrolyzed collagen concentrate is 20%.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110438853XA CN102488713B (en) | 2011-12-26 | 2011-12-26 | Method for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrated solution |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110438853XA CN102488713B (en) | 2011-12-26 | 2011-12-26 | Method for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrated solution |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102488713A true CN102488713A (en) | 2012-06-13 |
CN102488713B CN102488713B (en) | 2013-04-03 |
Family
ID=46180620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110438853XA Expired - Fee Related CN102488713B (en) | 2011-12-26 | 2011-12-26 | Method for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrated solution |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102488713B (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014121067A1 (en) * | 2013-02-01 | 2014-08-07 | Children's Medical Center Corporation | Collagen scaffolds |
CN106942506A (en) * | 2016-10-16 | 2017-07-14 | 长沙协浩吉生物工程有限公司 | A kind of compound method of nonreactive zinc-rich laying hen nutrition liquid |
CN107012526A (en) * | 2017-06-01 | 2017-08-04 | 合肥创沃科技有限公司 | A kind of preparation method of the composite regenerated fiber repair materials of Goat Placenta |
CN107213165A (en) * | 2017-06-29 | 2017-09-29 | 佛山市南海区普罗圣塔生物科技有限公司 | Placenta hydrolysis ultrafiltrate and preparation method thereof, using and feminine care gel |
CN107281223A (en) * | 2017-06-29 | 2017-10-24 | 佛山市南海区普罗圣塔生物科技有限公司 | The method for hydrolyzing placenta, the ultrafiltrate and placenta desciccate that are obtained with this method |
CN108323750A (en) * | 2017-01-20 | 2018-07-27 | 内蒙古草原鑫河食品有限公司 | A kind of active constituent and its extracting method and application with liver protection |
CN109602687A (en) * | 2019-02-20 | 2019-04-12 | 王清秀 | A kind of whitening spot-eliminating composition |
CN109943614A (en) * | 2019-04-02 | 2019-06-28 | 河北康进生物科技有限公司 | A kind of preparation method and applications of Goat Placenta active peptide |
CN104195205B (en) * | 2014-04-24 | 2019-08-16 | 吉林金梓源生物科技股份有限公司 | Method and prepared high activity collagen peptide and application thereof from animal placenta preparation high activity collagen peptide |
CN110903342A (en) * | 2019-12-13 | 2020-03-24 | 吉林省长源药业有限公司 | A biochemical extraction system |
US10786238B2 (en) | 2006-01-25 | 2020-09-29 | The Children's Medical Center Corporation | Methods and procedures for ligament repair |
CN113577005A (en) * | 2021-08-02 | 2021-11-02 | 京美瑞禾健康科技(辽宁)有限公司 | Sheep placenta ultramicro factor mask liquid and preparation method thereof |
US11484578B2 (en) | 2012-02-01 | 2022-11-01 | Children's Medical Center Corporation | Biomaterial for articular cartilage maintenance and treatment of arthritis |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1235026A (en) * | 1999-05-28 | 1999-11-17 | 孙月英 | Preparing method for injection of placenta peptide and products thereof |
CN1273096A (en) * | 2000-04-07 | 2000-11-15 | 吴文惠 | Process for extracting sheep placenta extract |
CN1333294A (en) * | 2000-07-11 | 2002-01-30 | 张建军 | Novel process for extracting purified sheed fetal agent and method for testing biological activity thereof |
CN1896268A (en) * | 2006-06-27 | 2007-01-17 | 扬州大学 | Extraction of activated micromolecular sheept germine from sheep embryo and its use |
CN101658534A (en) * | 2009-09-04 | 2010-03-03 | 黄继红 | Method for extracting sheep embryo bioelement from sheep placenta by utilizing low temperature of liquid nitrogen |
-
2011
- 2011-12-26 CN CN201110438853XA patent/CN102488713B/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1235026A (en) * | 1999-05-28 | 1999-11-17 | 孙月英 | Preparing method for injection of placenta peptide and products thereof |
CN1273096A (en) * | 2000-04-07 | 2000-11-15 | 吴文惠 | Process for extracting sheep placenta extract |
CN1333294A (en) * | 2000-07-11 | 2002-01-30 | 张建军 | Novel process for extracting purified sheed fetal agent and method for testing biological activity thereof |
CN1896268A (en) * | 2006-06-27 | 2007-01-17 | 扬州大学 | Extraction of activated micromolecular sheept germine from sheep embryo and its use |
CN101658534A (en) * | 2009-09-04 | 2010-03-03 | 黄继红 | Method for extracting sheep embryo bioelement from sheep placenta by utilizing low temperature of liquid nitrogen |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11076846B2 (en) | 2006-01-25 | 2021-08-03 | The Children's Medical Center Corporation | Methods and procedures for ligament repair |
US10786239B2 (en) | 2006-01-25 | 2020-09-29 | The Children's Medical Center Corporation | Methods and procedures for ligament repair |
US10786232B2 (en) | 2006-01-25 | 2020-09-29 | The Children's Medical Center Corporation | Methods and procedures for ligament repair |
US10786238B2 (en) | 2006-01-25 | 2020-09-29 | The Children's Medical Center Corporation | Methods and procedures for ligament repair |
US11076845B2 (en) | 2006-01-25 | 2021-08-03 | The Children's Medical Center Corporation | Methods and procedures for ligament repair |
US11484578B2 (en) | 2012-02-01 | 2022-11-01 | Children's Medical Center Corporation | Biomaterial for articular cartilage maintenance and treatment of arthritis |
US11826489B2 (en) | 2013-02-01 | 2023-11-28 | The Children's Medical Center Corporation | Collagen scaffolds |
WO2014121067A1 (en) * | 2013-02-01 | 2014-08-07 | Children's Medical Center Corporation | Collagen scaffolds |
US11839696B2 (en) | 2013-02-01 | 2023-12-12 | The Children's Medical Center Corporation | Collagen scaffolds |
US9757495B2 (en) | 2013-02-01 | 2017-09-12 | Children's Medical Center Corporation | Collagen scaffolds |
US10842914B2 (en) | 2013-02-01 | 2020-11-24 | The Children's Medical Center Corporation | Collagen scaffolds |
EP3798226A1 (en) * | 2013-02-01 | 2021-03-31 | Children's Medical Center Corporation | Collagen scaffolds |
CN104195205B (en) * | 2014-04-24 | 2019-08-16 | 吉林金梓源生物科技股份有限公司 | Method and prepared high activity collagen peptide and application thereof from animal placenta preparation high activity collagen peptide |
CN106942506A (en) * | 2016-10-16 | 2017-07-14 | 长沙协浩吉生物工程有限公司 | A kind of compound method of nonreactive zinc-rich laying hen nutrition liquid |
CN108323750A (en) * | 2017-01-20 | 2018-07-27 | 内蒙古草原鑫河食品有限公司 | A kind of active constituent and its extracting method and application with liver protection |
CN107012526A (en) * | 2017-06-01 | 2017-08-04 | 合肥创沃科技有限公司 | A kind of preparation method of the composite regenerated fiber repair materials of Goat Placenta |
CN107281223A (en) * | 2017-06-29 | 2017-10-24 | 佛山市南海区普罗圣塔生物科技有限公司 | The method for hydrolyzing placenta, the ultrafiltrate and placenta desciccate that are obtained with this method |
CN107213165A (en) * | 2017-06-29 | 2017-09-29 | 佛山市南海区普罗圣塔生物科技有限公司 | Placenta hydrolysis ultrafiltrate and preparation method thereof, using and feminine care gel |
CN109602687A (en) * | 2019-02-20 | 2019-04-12 | 王清秀 | A kind of whitening spot-eliminating composition |
CN109943614A (en) * | 2019-04-02 | 2019-06-28 | 河北康进生物科技有限公司 | A kind of preparation method and applications of Goat Placenta active peptide |
CN110903342A (en) * | 2019-12-13 | 2020-03-24 | 吉林省长源药业有限公司 | A biochemical extraction system |
CN113577005A (en) * | 2021-08-02 | 2021-11-02 | 京美瑞禾健康科技(辽宁)有限公司 | Sheep placenta ultramicro factor mask liquid and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN102488713B (en) | 2013-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102488713A (en) | Method for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrated solution | |
CN104513843B (en) | A kind of combined preparation process of polysaccharide and protein peptides | |
CN103772523B (en) | A kind of membrane separation and purification technology prepares Pachymose extract novel process | |
CN103160559B (en) | The preparation method of modified corn gliadin peptide | |
CN100376684C (en) | Method for preparing bacteriostatic peptide from low-grade tobacco leaf protein | |
CN101869169B (en) | Method for preparing fish oligopeptide from gurry by combining fermentation and membrane technology | |
CN102406048B (en) | Method for preparing sea cucumber glycoprotein by using sea cucumber blanching solution | |
CN105124132A (en) | Method for ultrasonic-assisted weak base extraction of proteins in cold-pressed sesame cake meal | |
CN106397630A (en) | Method for extracting sodium hyaluronate based on membrane separation technology | |
CN1896267B (en) | Preparation of depressor peptide by silkworm chrysalis | |
CN108690099A (en) | A method of the extraction separation procyanidine from black fruit fructus lycii | |
CN103937859A (en) | Method for preparing gelatin by using bone meal as raw material through enzyme method | |
CN103627768A (en) | Fish skin collagen bioactive small peptide and preparation method thereof | |
CN107522794A (en) | A kind of bletilla striata polyoses glue extracting method | |
CN102924591A (en) | Preparation method of fresh jellyfish collagens | |
CN108101980B (en) | Preparation method of high-purity phycocyanin | |
CN106348429A (en) | Kudzuvine root resource utilization method for flavonol, starch and amino acid separation and purification | |
CN106496363A (en) | A kind of efficient preparation technology of heparin sodium | |
CN106119328A (en) | A kind of high-quality shrimp oligopeptide powder, preparation method thereof of applicable industrialized production | |
CN102180991B (en) | Comprehensive utilization method of pumpkin | |
CN102718831B (en) | Preparation method for manufacturing silkworm pupa protein of protein filament | |
CN101215422A (en) | The Refining Method of Lac Red Pigment | |
CN109880872A (en) | A method of extracting collagen peptide from sturgeon | |
CN106318995B (en) | Method for preparing levan and gluconic acid by using inulin | |
CN108070015B (en) | A method for simultaneously recovering ethanol and tea saponin from the water phase after extracting camellia oil by ethanol water extraction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130403 Termination date: 20141226 |
|
EXPY | Termination of patent right or utility model |